Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset reduced a painful complication of sickle cell disease (SCD) in a phase 3 study.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The LMP Capital and Income Fund (SCD) is a closed-end fund that aims to provide its investors with a high level of current income along with capital appreciation through investments in a portfolio ...

I caused an N+1 Query bug in my demo app, but it's not being recognized as an N+1 Query issue. There are quick pg-pool.connect spans in between the queries that don't meet all of the N+1 Query ...

The first patient has been enrolled in a Phase 1 clinical trial evaluating the safety and tolerability of Rigel Pharmaceuticals’ fostamatinib — a medication approved in the U.S. for treating an ...

The incidence of stroke continues to increase for adults and children living with sickle cell disease (SCD) despite the Stroke Prevention Trial in Sickle Cell Anemia (STOP) establishing standards of ...

A cross-sectional analysis assessed the birth prevalence of sickle cell disease (SCD) alongside data on social vulnerability to highlight the needs of communities impacted by SCD. SCD, a blood ...

Please provide your email address to receive an email when new articles are posted on . The incidence of sudden cardiac death among college athletes decreased over past 20 years. Incidence of sudden ...